PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 61 filers reported holding PEAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $12,813,679 | -42.2% | 10,859,050 | 0.0% | 23.91% | +7.0% |
| Q3 2022 | $22,152,000 | +32.5% | 10,859,050 | 0.0% | 22.34% | +20.3% |
| Q2 2022 | $16,723,000 | -69.5% | 10,859,050 | 0.0% | 18.57% | -58.3% |
| Q1 2022 | $54,838,000 | -18.5% | 10,859,050 | 0.0% | 44.55% | +14.9% |
| Q4 2021 | $67,326,000 | – | 10,859,050 | – | 38.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roble, Belko & Company, Inc | 4,502 | $0 | 0.00% |